| Literature DB >> 21790952 |
H Pattison1, J P Daniels, J Kai, J K Gupta.
Abstract
Menorrhagia, or heavy menstrual bleeding (HMB), is a common gynaecological condition. As the aim of treatment is to improve women's wellbeing and quality of life (QoL), it is necessary to have effective ways to measure this. This study investigated the reliability and validity of the menorrhagia multi-attribute scale (MMAS), a menorrhagia-specific QoL instrument. Participants (n = 431) completed the MMAS and a battery of other tests as part of the baseline assessment of the ECLIPSE (Effectiveness and Cost-effectiveness of Levonorgestrel-containing Intrauterine system in Primary care against Standard trEatment for menorrhagia) trial. Analyses of their responses suggest that the MMAS has good measurement properties and is therefore an appropriate condition-specific instrument to measure the outcome of treatment for HMB.Entities:
Mesh：
Substances：
Year: 2011 PMID： 21790952 DOI： 10.1111/j.1471-0528.2011.03057.x
Source DB: PubMed Journal: BJOG ISSN： 1470-0328 Impact factor: 6.531